Recombinant DNA technology and its impact on modern drug discovery

<p>The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological.</p> <p>Recombinant DNA is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and antibodies to expedite the process of novel drug identification and validation, for example.</p> <p>Chen talks with DDW Publishing Director Lu Rahman about the origins, importance and possible applications of recombinant DNA technology in drug discovery – as well as the opportunities it creates for drug discovery research.</p>